Redefining Diagnostic and Management Approaches to Vancomycin Adverse Drug Reactions
- 6 May 2026
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (5) , 1034-1047
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (1UG3AI190386)
- Foundation of the American College of Allergy, Asthma & Immunology
- National Institutes of Health
This publication has 87 references indexed in Scilit:
- Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms SyndromeJAMA Dermatology, 2022
- HLA-A*32:01 ASSOCIATED VANCOMYCIN-INDUCED DRESS SYNDROME AND DESQUAMATION IN AN AFRICAN AMERICAN WOMANAnnals of Allergy, Asthma & Immunology, 2022
- Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the USJAMA Dermatology, 2022
- Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisJAMA Dermatology, 2021
- A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure InfectionsInfectious Diseases and Therapy, 2020
- Evaluation of dalbavancin on length of stay in acute bacterial skin and skin structure infectionsJACCP: Journal of the American College of Clinical Pharmacy, 2019
- Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012JAMA Internal Medicine, 2016
- Redesigning the allergy module of the electronic health recordAnnals of Allergy, Asthma & Immunology, 2016
- Immune-mediated reactions to vancomycinAnnals of Allergy, Asthma & Immunology, 2016
- Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance AuthorityEuropean Journal of Clinical Pharmacology, 2012